Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheila A Doggrell

Showing results (1-10 of 220) with videos related to

Pageof 22
Sort By:
Expert Opinion on Investigational Drugs|June 24, 2021
Still grasping at straws: donanemab in Alzheimer's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|August 20, 2019
Lessons that can be learnt from the failure of verubecestat in Alzheimer's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|December 2, 2004
Which drug combination for colorectal cancer?Sheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|October 21, 2003
Present and future pharmacotherapy for osteoporosisSheila A Doggrell
Expert Opinion on Investigational Drugs|October 31, 2003
Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growthSheila A Doggrell
Expert Opinion on Pharmacotherapy|June 24, 2004
Recent important clinical trials of drugs in osteoporosisSheila A Doggrell
Expert Opinion on Pharmacotherapy|July 22, 2004
New drugs for the prevention and treatment of migraine: topiramate and BIBN 4096 BSSheila A Doggrell
Drug News & Perspectives|December 18, 2004
Focus on vascular pharmacologySheila A Doggrell
Expert Opinion on Investigational Drugs|November 30, 2004
Alpha-lipoic acid, an anti-obesity agent?Sheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|October 27, 2004
Tolvaptan (Otsuka)Sheila A Doggrell
Pageof 22

Showing results (1-10 of 220) with videos related to

Sort By:
Pageof 22
Expert Opinion on Investigational Drugs|June 24, 2021
Still grasping at straws: donanemab in Alzheimer's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|August 20, 2019
Lessons that can be learnt from the failure of verubecestat in Alzheimer's diseaseSheila A Doggrell
Expert Opinion on Pharmacotherapy|December 2, 2004
Which drug combination for colorectal cancer?Sheila A Doggrell
Drugs of Today (Barcelona, Spain : 1998)|October 21, 2003
Present and future pharmacotherapy for osteoporosisSheila A Doggrell
Expert Opinion on Investigational Drugs|October 31, 2003
Experimental and clinical studies show that the probucol derivative AGI-1067 prevents vascular growthSheila A Doggrell
Expert Opinion on Pharmacotherapy|June 24, 2004
Recent important clinical trials of drugs in osteoporosisSheila A Doggrell
Expert Opinion on Pharmacotherapy|July 22, 2004
New drugs for the prevention and treatment of migraine: topiramate and BIBN 4096 BSSheila A Doggrell
Drug News & Perspectives|December 18, 2004
Focus on vascular pharmacologySheila A Doggrell
Expert Opinion on Investigational Drugs|November 30, 2004
Alpha-lipoic acid, an anti-obesity agent?Sheila A Doggrell
Current Opinion in Investigational Drugs (London, England : 2000)|October 27, 2004
Tolvaptan (Otsuka)Sheila A Doggrell
Pageof 22